WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
Volume
Vol 1d %
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
RSI
Stochastic %K
Stochastic %D
StochRSI %K
StochRSI %D
MACD
MACD Signal
MACD Histogram
Beta
ICLR
ICON PLC
$314.72224,336-9.32%314.93309.26316.67299.49277.9452.9080.8981.7876.9983.031.700.251.450.97
STRR
STAR EQUITY HOLDINGS INC
$0.8820,65224.68%0.900.900.900.940.9743.3331.4838.520.0011.43-0.00-0.00-0.000.54
FONR
FONAR CORP
$15.2432,88315.61%16.6616.4318.6719.6418.0132.8614.9425.7540.3550.59-0.64-0.660.020.61
TMO
THERMO FISHER SCIENTIFIC INC
$595.301,394,0829.27%586.80578.90577.00564.35532.5763.0986.7989.2188.9993.547.024.262.760.83
IDXX
IDEXX LABORATORIES INC
$543.45445,160-14.90%511.53499.70512.42531.24500.8665.2594.7494.2293.4394.927.38-1.028.401.04
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$221.61927,568-28.73%230.52231.57246.28238.44218.2035.0529.3541.0328.4352.36-4.53-4.48-0.061.16
ENZ
ENZO BIOCHEM INC
$1.0931,340-70.34%1.081.071.161.251.3246.5175.4175.3593.9893.65-0.02-0.030.010.46
DGX
QUEST DIAGNOSTICS INC
$144.341,422,73944.18%139.28137.79132.89131.72131.1568.6690.8580.8986.2671.102.762.250.510.61
MEDP
MEDPACE HOLDINGS INC
$393.30118,631-23.05%396.01394.84396.46364.72314.6649.5157.9660.6551.6159.660.880.800.081.23
SHC
SOTERA HEALTH CO
$11.29467,492-3.19%11.3211.2711.7613.7114.2446.4468.1370.5493.5397.72-0.12-0.200.081.24
NEOG
NEOGEN CORP
$13.542,408,36519.94%12.7512.4813.5915.5017.0859.1189.1589.09100.00100.00-0.04-0.300.261.01
LAB
STANDARD BIOTOOLS INC
$2.572,935,424-9.11%2.452.472.602.462.4353.4178.3377.0494.9596.31-0.02-0.040.021.30
A
AGILENT TECHNOLOGIES INC
$154.231,830,47138.16%148.12142.91143.58138.89128.4170.1796.3193.1099.7297.373.441.701.750.97
QGEN
QIAGEN NV
$45.691,274,89918.16%44.2843.1642.6643.5842.9872.4297.2898.6093.5597.850.990.590.400.42
DHR
DANAHER CORP
$265.803,167,015-7.86%255.55251.15248.81244.77236.9573.8298.1594.87100.0096.004.442.382.070.85
FLGT
FULGENT GENETICS INC
$22.1193,330-29.72%21.9321.2921.4623.7526.2158.0182.1083.3987.6495.310.280.090.191.26
SERA
SERA PROGNOSTICS INC
$8.26141,8044.35%0.780.770.900.870.9348.2363.2963.3484.5389.54-0.02-0.030.010.75
CSTL
CASTLE BIOSCIENCES INC
$24.24246,347-13.71%24.1422.6321.2921.7519.6763.6270.8172.7761.9467.900.970.850.121.13
EXAS
EXACT SCIENCES CORP
$50.382,449,996-0.74%55.7258.2462.6763.6267.1928.893.289.595.5412.98-3.23-2.42-0.811.31
NTRA
NATERA INC
$106.46938,873-10.71%102.2097.3993.9281.7466.1968.3193.2090.7888.0789.084.203.051.161.38
PRE
PRENETICS GLOBAL LTD
$5.801,946-91.36%5.765.264.574.775.6460.4382.8282.4149.1264.690.460.410.050.60
RVTY
REVVITY INC
$110.231,061,545-13.56%105.60103.92104.28105.62104.4567.7290.6986.88100.00100.001.220.350.870.87
CHEK
CHECK-CAP LTD
$2.1914,0083.22%2.202.222.262.202.7245.8962.5660.7847.5029.17-0.03-0.03-0.000.54
OLK
OLINK HOLDING AB (PUBL)
$23.95140,521-55.03%23.5723.1723.3523.8022.0263.5885.5686.2095.1097.550.220.090.131.51
LH
LABCORP HOLDINGS INC
$210.59730,35210.10%207.65205.03208.26215.53212.3057.6686.0191.2190.4896.731.14-0.391.530.91
WAT
WATERS CORP
$355.95387,331-0.34%344.38328.15333.88328.47301.3365.6686.9790.9592.5696.469.043.885.160.92
PRPO
PRECIPIO INC
$6.2914,773156.12%6.076.016.226.286.6053.5072.0680.5275.6983.30-0.01-0.070.060.74
DRIO
DARIOHEALTH CORP
$1.90153,149-59.63%1.721.591.491.742.0369.1096.6393.41100.0097.670.110.060.041.17
NEO
NEOGENOMICS INC
$14.80639,9800.01%15.3414.8114.8215.2915.2648.6756.0764.1537.0554.380.170.150.011.43
TWST
TWIST BIOSCIENCE CORP
$47.01649,296-11.74%45.2238.7535.3735.9928.8969.3184.0988.3975.8681.543.982.951.031.75
IQV
IQVIA HOLDINGS INC
$231.18715,158-29.11%230.74231.64239.97233.59220.7347.4472.8565.6391.5388.70-1.54-2.470.931.18
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,522.75142,115-1.74%1,408.331,323.351,306.471,256.961,186.0474.7297.8095.5684.7983.1966.7735.3931.381.01
BNR
BURNING ROCK BIOTECH LTD
$8.306,59312.91%8.018.087.658.199.4156.0353.0251.0578.8167.620.100.080.021.02
ACRS
ACLARIS THERAPEUTICS INC
$1.19446,24910.34%1.221.231.221.203.1045.5016.4815.636.965.57-0.01-0.00-0.011.02
RDNT
RADNET INC
$57.45303,106-20.23%54.9652.1449.2643.6637.2973.0493.1496.3887.1793.782.571.980.591.35
CDNA
CAREDX INC
$15.50883,32436.78%13.2010.7810.1410.139.1879.0786.8587.3791.4393.881.630.980.651.52
PSNL
PERSONALIS INC
$1.40154,836-10.03%1.521.461.451.521.4545.4323.0434.397.5825.720.020.03-0.011.58
STIM
NEURONETICS INC
$2.61207,32649.79%2.643.133.813.512.5234.289.096.0420.4311.72-0.39-0.34-0.051.29
ME
23ANDME HOLDING CO
$0.592,165,031-20.12%0.540.510.490.600.8061.0872.1078.6874.3183.460.030.010.011.67
GH
GUARDANT HEALTH INC
$25.362,430,880-27.45%22.4520.2019.0120.9625.1273.5989.3391.9692.7197.571.871.040.841.34
XWEL
XWELL INC
$1.748,75042.65%1.821.761.711.712.2249.9231.6740.3612.1615.590.050.05-0.001.19
OCX
ONCOCYTE CORP
$2.9331,516-69.97%2.882.712.822.953.0957.6189.3994.3589.3696.320.060.010.051.20
MYGN
MYRIAD GENETICS INC
$25.29598,427-33.45%23.9321.4321.0621.1719.1671.2585.7086.6876.1581.821.410.880.531.37
DMTK
DERMTECH INC
$0.50648,733253.12%0.600.610.640.981.3528.225.7722.820.6930.11-0.03-0.03-0.001.22
XGN
EXAGEN INC
$1.8828,814-62.52%1.621.511.551.781.9174.4184.3480.9895.6997.990.080.020.071.34
PRPH
PROPHASE LABS INC
$5.0353,904-30.44%5.145.075.595.255.0245.3254.9957.4575.8678.88-0.15-0.160.020.29
AWH
ASPIRA WOMEN's HEALTH INC
$2.6648,79543.74%2.903.113.253.884.0028.278.3015.662.834.77-0.17-0.13-0.050.94
NDRA
ENDRA LIFE SCIENCES INC
$0.31457,695429.32%0.300.290.510.871.0140.7831.0134.2177.8274.77-0.05-0.070.020.92
VNRX
VOLITIONRX LTD
$0.7775,23547.74%0.790.820.790.890.9047.8129.1728.4632.1432.560.000.00-0.000.98
MDXH
MDXHEALTH SA
$2.8835,97825.23%2.922.762.653.233.1355.3053.1654.0531.0533.750.070.060.010.42
GENE
GENETIC TECHNOLOGIES LTD
$2.2824,920-32.47%2.352.322.602.3935.3741.6549.2267.5363.2881.30-0.09-0.110.020.66
NOTV
INOTIV INC
$1.93755,561-24.25%3.473.856.435.594.3125.9911.5515.095.4213.82-1.03-0.89-0.131.12
BIAF
BIOAFFINITY TECHNOLOGIES INC
$2.26132,210-67.46%2.062.262.271.961.7350.7346.1428.2958.3232.33-0.07-0.07-0.000.83
MYNZ
MAINZ BIOMED NV
$0.6883,469-68.99%0.680.760.920.971.7036.9417.4912.0230.2916.07-0.08-0.08-0.000.68
ILMN
ILLUMINA INC
$111.071,035,5613.88%113.32117.92125.12132.15133.2436.2525.7029.9148.1153.68-3.71-3.67-0.051.09
OPK
OPKO HEALTH INC
$1.322,789,85028.63%1.291.271.181.121.3457.8782.5479.9559.6258.270.030.03-0.001.20
PMD
PSYCHEMEDICS CORP
$2.582,949-70.31%2.572.582.752.983.1545.3621.7428.0254.9465.02-0.05-0.060.010.46
APDN
APPLIED DNA SCIENCES INC
$2.5163,539-19.55%3.273.956.669.4015.5217.7410.1917.1624.9042.38-1.17-1.210.040.18
TRIB
TRINITY BIOTECH PLC
$1.583,798-89.68%1.621.711.902.142.5536.0711.868.7331.6518.82-0.10-0.09-0.010.35
BDSX
BIODESIX INC
$1.5850,929-39.10%1.541.411.391.601.5666.0581.3676.0979.3975.110.060.040.021.12
MMA
ALTA GLOBAL GROUP LTD
$4.5421,994-71.83%3.993.58N/AN/AN/A65.2579.3685.9077.2388.33N/AN/AN/A1.27
ISPC
ISPECIMEN INC
$0.24408,134-35.90%0.250.270.280.380.5445.3925.2417.9648.3132.71-0.01-0.01-0.000.76
TTOO
T2 BIOSYSTEMS INC
$5.64179,842-72.66%4.263.673.464.2711.3470.5078.4678.8889.1491.340.530.230.301.09
CNTG
CENTOGENE NV
$0.37499,496-80.66%0.400.430.560.800.9630.7514.4419.9746.6164.12-0.05-0.060.000.41

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the top diagnostic & research stock with a Zen Score of 47, which is 21 points higher than the diagnostic & research industry average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 49.4% over the past year, overperforming other diagnostic & research stocks by 38 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 9.42% from Icon's current stock price of $314.72.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the second best diagnostic & research stock with a Zen Score of 46, which is 20 points higher than the diagnostic & research industry average of 26. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 10% over the past year, underperforming other diagnostic & research stocks by -1 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third best diagnostic & research stock with a Zen Score of 43, which is 17 points higher than the diagnostic & research industry average of 26. It passed 13 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock lose -9.98% over the past year, underperforming other diagnostic & research stocks by -21 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.8%, which is 2 percentage points higher than the diagnostic & research industry average of 1.25%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2%, which is 1 percentage points higher than the diagnostic & research industry average of 1.25%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Labcorp Holdings (NYSE:LH)


Labcorp Holdings (NYSE:LH) has an annual dividend yield of 1.03%, which is the same as the diagnostic & research industry average of 1.25%. Labcorp Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Labcorp Holdings's dividend has not shown consistent growth over the last 10 years.

Labcorp Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks down?

Diagnostic & research stocks were down -0.44% in the last day, and up 1.56% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are down.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 10% in the past year. It has underperformed other stocks in the diagnostic & research industry by -1 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -52.81% in the past year. It has underperformed other stocks in the diagnostic & research industry by -64 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 53 points higher than the diagnostic & research industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has dropped -9.98% in the past year. It has underperformed other stocks in the diagnostic & research industry by -21 percentage points.

Are diagnostic & research stocks a good buy now?

52.08% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 5.02% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.96x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.